Schedule 13G ownership disclosure
KEMPHARM, INC
Security class unavailable · CUSIP: 488445107
Event date: Unavailable
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 998,742
- Percent of class
- 6.8000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001453072-17-000013
- Form type
- SC 13G
- Filer
- Alyeska Investment Group, L.P.
- CIK
- CIK 1453072
- Filed
- Feb 14, 2017
- Reporting period
- —
- Description
- Schedule 13G beneficial ownership